nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicergoline—ADRA1A—polycystic ovary syndrome	0.949	1	CbGaD
Nicergoline—ADRA1A—Adrenoceptors—ADRA1D—polycystic ovary syndrome	0.00384	0.0754	CbGpPWpGaD
Nicergoline—ADRA1A—Adrenoceptors—ADRA1B—polycystic ovary syndrome	0.00374	0.0734	CbGpPWpGaD
Nicergoline—ADRA1A—Adrenoceptors—ADRB3—polycystic ovary syndrome	0.00273	0.0535	CbGpPWpGaD
Nicergoline—ADRA1A—Adrenoceptors—ADRB2—polycystic ovary syndrome	0.00147	0.0289	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—ADIPOR1—polycystic ovary syndrome	0.00139	0.0274	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—ADIPOR2—polycystic ovary syndrome	0.00139	0.0274	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.00136	0.0267	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.00132	0.0259	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.00114	0.0224	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.00111	0.0218	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.000964	0.0189	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (12/13) signalling events—PLEKHG5—polycystic ovary syndrome	0.00084	0.0165	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.00081	0.0159	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—INS-IGF2—polycystic ovary syndrome	0.000801	0.0157	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—ADRA1B—polycystic ovary syndrome	0.000732	0.0144	CbGpPWpGaD
Nicergoline—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000721	0.0142	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (12/13) signalling events—ADRA1D—polycystic ovary syndrome	0.000704	0.0138	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (12/13) signalling events—ADRA1B—polycystic ovary syndrome	0.000685	0.0135	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.000521	0.0102	CbGpPWpGaD
Nicergoline—ADRA1A—Endothelin Pathways—GNAS—polycystic ovary syndrome	0.000483	0.00948	CbGpPWpGaD
Nicergoline—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000471	0.00925	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.000438	0.00859	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.000407	0.00798	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—INSR—polycystic ovary syndrome	0.000405	0.00795	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.000396	0.00777	CbGpPWpGaD
Nicergoline—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000394	0.00773	CbGpPWpGaD
Nicergoline—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000379	0.00744	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.000349	0.00686	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.000339	0.00666	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—ADIPOQ—polycystic ovary syndrome	0.000338	0.00663	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—CCNB1—polycystic ovary syndrome	0.000338	0.00663	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.00033	0.00648	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—SLC2A4—polycystic ovary syndrome	0.000319	0.00626	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.000312	0.00613	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.000303	0.00595	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.000296	0.00582	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.000295	0.00579	CbGpPWpGaD
Nicergoline—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000293	0.00575	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.000289	0.00567	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.000289	0.00567	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.000289	0.00567	CbGpPWpGaD
Nicergoline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000276	0.00542	CbGpPWpGaD
Nicergoline—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000272	0.00534	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00027	0.0053	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.000262	0.00515	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000258	0.00507	CbGpPWpGaD
Nicergoline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000256	0.00503	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.000255	0.00501	CbGpPWpGaD
Nicergoline—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000253	0.00497	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000247	0.00486	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000247	0.00486	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.000232	0.00456	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000231	0.00454	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000226	0.00443	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000225	0.00441	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000224	0.00439	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000218	0.00429	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000211	0.00415	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—LEP—polycystic ovary syndrome	0.00021	0.00412	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000208	0.00408	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.000208	0.00408	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000208	0.00408	CbGpPWpGaD
Nicergoline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000203	0.00398	CbGpPWpGaD
Nicergoline—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.0002	0.00393	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000188	0.0037	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000188	0.0037	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000186	0.00365	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000181	0.00355	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000176	0.00346	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—AKT2—polycystic ovary syndrome	0.000173	0.0034	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000171	0.00336	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000166	0.00327	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000165	0.00323	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000164	0.00323	CbGpPWpGaD
Nicergoline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000164	0.00321	CbGpPWpGaD
Nicergoline—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000161	0.00317	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000159	0.00313	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000157	0.00309	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.000157	0.00308	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.000156	0.00306	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000154	0.00302	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000145	0.00284	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000144	0.00282	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000141	0.00276	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00014	0.00276	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000138	0.00271	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000134	0.00263	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000133	0.0026	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000132	0.0026	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000128	0.0025	CbGpPWpGaD
Nicergoline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000122	0.00239	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000121	0.00238	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00012	0.00235	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000119	0.00233	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000117	0.0023	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000117	0.0023	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000116	0.00227	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000115	0.00226	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000113	0.00222	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000113	0.00222	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000112	0.00221	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000111	0.00217	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00011	0.00217	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000109	0.00214	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000107	0.0021	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000106	0.00209	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000106	0.00209	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000105	0.00206	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000104	0.00204	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0001	0.00197	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	9.96e-05	0.00195	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	9.89e-05	0.00194	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	9.67e-05	0.0019	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	9.67e-05	0.0019	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	9.66e-05	0.0019	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	9.4e-05	0.00185	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	9.04e-05	0.00177	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	8.78e-05	0.00172	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	8.74e-05	0.00172	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	8.62e-05	0.00169	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	8.61e-05	0.00169	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	8.55e-05	0.00168	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	8.54e-05	0.00168	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	7.92e-05	0.00155	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	7.83e-05	0.00154	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	7.79e-05	0.00153	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	7.77e-05	0.00152	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	7.07e-05	0.00139	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	7.04e-05	0.00138	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.95e-05	0.00136	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	6.86e-05	0.00135	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	6.84e-05	0.00134	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	6.78e-05	0.00133	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	6.62e-05	0.0013	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	6.55e-05	0.00129	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	6.35e-05	0.00125	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	6.23e-05	0.00122	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	6.2e-05	0.00122	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.19e-05	0.00121	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	6.15e-05	0.00121	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	6.08e-05	0.00119	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	6.06e-05	0.00119	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	6.02e-05	0.00118	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	5.77e-05	0.00113	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	5.71e-05	0.00112	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	5.71e-05	0.00112	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	5.67e-05	0.00111	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	5.67e-05	0.00111	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	5.5e-05	0.00108	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	5.37e-05	0.00105	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.34e-05	0.00105	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	5.27e-05	0.00103	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	5.25e-05	0.00103	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.18e-05	0.00102	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.04e-05	0.00099	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	4.92e-05	0.000965	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.59e-05	0.000901	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	4.48e-05	0.000879	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	4.48e-05	0.000879	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	4.47e-05	0.000878	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	4.18e-05	0.00082	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	4.09e-05	0.000803	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	4.06e-05	0.000798	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.93e-05	0.000771	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	3.75e-05	0.000737	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	3.72e-05	0.000731	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.7e-05	0.000727	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.68e-05	0.000722	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	3.64e-05	0.000714	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	3.56e-05	0.000699	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.55e-05	0.000698	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.44e-05	0.000676	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.43e-05	0.000674	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	3.41e-05	0.000669	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	3.4e-05	0.000667	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.36e-05	0.00066	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.25e-05	0.000638	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	3.19e-05	0.000627	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	3.17e-05	0.000622	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	3.15e-05	0.000619	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.12e-05	0.000612	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	3.03e-05	0.000594	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.96e-05	0.00058	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.92e-05	0.000573	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.89e-05	0.000567	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.79e-05	0.000547	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.65e-05	0.00052	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.63e-05	0.000517	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.61e-05	0.000512	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	2.58e-05	0.000507	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.57e-05	0.000505	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.49e-05	0.000489	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	2.4e-05	0.000471	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	2.4e-05	0.000471	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.31e-05	0.000454	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.29e-05	0.00045	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.29e-05	0.00045	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.23e-05	0.000438	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.22e-05	0.000436	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.22e-05	0.000436	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.14e-05	0.00042	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.11e-05	0.000415	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.1e-05	0.000412	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	2.09e-05	0.000411	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.06e-05	0.000404	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.03e-05	0.000399	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.02e-05	0.000396	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.99e-05	0.00039	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.92e-05	0.000377	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.89e-05	0.000371	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.84e-05	0.000362	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.76e-05	0.000345	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.72e-05	0.000338	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.63e-05	0.000321	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.59e-05	0.000312	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.49e-05	0.000293	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.48e-05	0.00029	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.44e-05	0.000283	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.33e-05	0.000262	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.29e-05	0.000253	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.27e-05	0.000249	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.24e-05	0.000244	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	1.23e-05	0.000242	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.2e-05	0.000237	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.19e-05	0.000234	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.19e-05	0.000234	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.13e-05	0.000222	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.12e-05	0.00022	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	9.12e-06	0.000179	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	9.11e-06	0.000179	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	8.98e-06	0.000176	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—INS—polycystic ovary syndrome	8.93e-06	0.000175	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.79e-06	0.000153	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	5.39e-06	0.000106	CbGpPWpGaD
